We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Advice on Replacement or Corrective Therapies for Certain Rare Diseases
FDA Issues Advice on Replacement or Corrective Therapies for Certain Rare Diseases
The FDA released a draft guidance Thursday recommending ways to demonstrate if new drugs or drug uses are effective for certain low-prevalence rare diseases caused by single enzyme defects.